We have located links that may give you full text access.
Predictors of aortic stenosis severity reclassification with imaging data fusion method in patients qualified for TAVI.
Kardiologia Polska 2018 September 14
B: ACKGROUND: Imaging data fusion method (IDFM) with multislice computed tomography (MSCT) and two-dimensional transthoracic echocardiography (2D-TTE) in aortic stenosis (AS) may result in reclassification from severe to non-severe AS.
AIM: The aim of the study was to establish potential predictors of AS reclassification with IDFM method.
METHODS: 54 high-risk patients (mean age 79±7.9 years; 40.7% male) with severe AS by 2D-TTE (indexed aortic valve area [AVAi] < 0.6 cm²/m²), qualified for transcatheter aortic valve implantation (TAVI), were included in the analysis. AVAi was then recalculated with IDFM by replacing 2D-TTE left ventricular outflow tract (LVOT) measurements with MSCT LVOT parameters.
RESULTS: IDFM reclassified 20.4% patients as potentially non-severe AS. In a multivariable model including clinical variables, reclassification to non-severe AS by IDFM was independently associated with younger age and diabetes mellitus (DM), (Odds Ratio (OR): 0.864; 95% CI: 0.76-0.99; P < 0.035 and OR: 19.259; 95% CI: 2.28-162.41; P < 0.007, respectively). In a multivariable model including echocardiographic variables, reclassification was associated with: higher LVOT velocity time integral (VTILVOT) and lower aortic mean gradient (AMG) (OR: 1.402; 95% CI: 1.07-1.84; P < 0.014 and OR: 0.858; 95%: CI: 0.760-0.968; P < 0.013, respectively). In addition 24.1% of patients were reallocated from low-flow (< 35 mL/m²) to normal-flow AS.
CONCLUSIONS: IDFM reclassified a substantial proportion of patients with severe AS into potentially moderate AS group and from low-flow to normal-flow AS group. Such regrouping calls for increased diagnostic prudence in AS patients, especially those with specific clinical and echocardiographic predictors of reclassification, such as DM or low AMG.
AIM: The aim of the study was to establish potential predictors of AS reclassification with IDFM method.
METHODS: 54 high-risk patients (mean age 79±7.9 years; 40.7% male) with severe AS by 2D-TTE (indexed aortic valve area [AVAi] < 0.6 cm²/m²), qualified for transcatheter aortic valve implantation (TAVI), were included in the analysis. AVAi was then recalculated with IDFM by replacing 2D-TTE left ventricular outflow tract (LVOT) measurements with MSCT LVOT parameters.
RESULTS: IDFM reclassified 20.4% patients as potentially non-severe AS. In a multivariable model including clinical variables, reclassification to non-severe AS by IDFM was independently associated with younger age and diabetes mellitus (DM), (Odds Ratio (OR): 0.864; 95% CI: 0.76-0.99; P < 0.035 and OR: 19.259; 95% CI: 2.28-162.41; P < 0.007, respectively). In a multivariable model including echocardiographic variables, reclassification was associated with: higher LVOT velocity time integral (VTILVOT) and lower aortic mean gradient (AMG) (OR: 1.402; 95% CI: 1.07-1.84; P < 0.014 and OR: 0.858; 95%: CI: 0.760-0.968; P < 0.013, respectively). In addition 24.1% of patients were reallocated from low-flow (< 35 mL/m²) to normal-flow AS.
CONCLUSIONS: IDFM reclassified a substantial proportion of patients with severe AS into potentially moderate AS group and from low-flow to normal-flow AS group. Such regrouping calls for increased diagnostic prudence in AS patients, especially those with specific clinical and echocardiographic predictors of reclassification, such as DM or low AMG.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app